• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中蒙特利尔认知评估各子部分的特定领域准确性。

Domain-specific accuracy of the Montreal Cognitive Assessment subsections in Parkinson's disease.

作者信息

Hendershott Taylor R, Zhu Delphine, Llanes Seoni, Poston Kathleen L

机构信息

Department of Neurology and Neurological Sciences, Stanford University School Medicine, 300 Pasteur Drive, Stanford, CA 94304, United States.

Department of Neurology and Neurological Sciences, Stanford University School Medicine, 300 Pasteur Drive, Stanford, CA 94304, United States; Department of Neurosurgery, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94304, United States.

出版信息

Parkinsonism Relat Disord. 2017 May;38:31-34. doi: 10.1016/j.parkreldis.2017.02.008. Epub 2017 Feb 7.

DOI:10.1016/j.parkreldis.2017.02.008
PMID:28215728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5400012/
Abstract

OBJECTIVE

The Montreal Cognitive Assessment (MoCA) is among the most widely adopted screening tools for cognitive impairment because it includes tests in multiple domains and is available in 55 languages. The MoCA is often the only formal cognitive assessment available when comprehensive neuropsychological testing is not practical, such as rural clinical settings or large retrospective and multi-lingual research settings. However, the MoCA domain-specific subsections have never been formally assessed for sensitivity or specificity. Therefore, in Parkinson's disease, we examined whether the subsections of the MoCA could identify cognitive impairment within specific cognitive domains.

METHODS

We administered a comprehensive neuropsychological battery to 85 Parkinson's disease participants, who were then categorized as with or without cognitive impairment, with respect to global cognition and in five cognitive domains. We then assessed the domain-specific categorization of the MoCA subsections compared to the full neuropsychology battery.

RESULTS

All MoCA subsections predicted impairment in their respective cognitive domain. However, the executive subsection showed the highest sensitivity and specificity (89.3% and 82.5%, respectively), followed by visuospatial (93.3% and 45.7%, respectively) and memory (84.6% and 56.5%, respectively).

CONCLUSION

The MoCA is a useful screening tool for PD global cognitive and executive functions. The MoCA is also highly sensitive to visuospatial and memory impairment, but with limited specificity and accuracy these subsections should be interpreted with caution.

摘要

目的

蒙特利尔认知评估量表(MoCA)是认知障碍最广泛采用的筛查工具之一,因为它包含多个领域的测试且有55种语言版本。当全面的神经心理学测试不可行时,例如在农村临床环境或大型回顾性及多语言研究环境中,MoCA常常是唯一可用的正式认知评估工具。然而,MoCA特定领域的子部分从未进行过敏感性或特异性的正式评估。因此,在帕金森病中,我们研究了MoCA的子部分是否能够识别特定认知领域内的认知障碍。

方法

我们对85名帕金森病参与者进行了全面的神经心理学测试,然后根据整体认知和五个认知领域将他们分为有或无认知障碍两类。然后我们将MoCA子部分的特定领域分类与完整的神经心理学测试进行了比较。

结果

所有MoCA子部分都能预测其各自认知领域的障碍。然而,执行功能子部分显示出最高的敏感性和特异性(分别为89.3%和82.5%),其次是视觉空间功能(分别为93.3%和45.7%)和记忆功能(分别为84.6%和56.5%)。

结论

MoCA是帕金森病整体认知和执行功能的有用筛查工具。MoCA对视觉空间和记忆障碍也高度敏感,但由于特异性和准确性有限这些子部分的解释应谨慎。

相似文献

1
Domain-specific accuracy of the Montreal Cognitive Assessment subsections in Parkinson's disease.帕金森病中蒙特利尔认知评估各子部分的特定领域准确性。
Parkinsonism Relat Disord. 2017 May;38:31-34. doi: 10.1016/j.parkreldis.2017.02.008. Epub 2017 Feb 7.
2
Cognitive impairment in Parkinson's disease: Association between patient-reported and clinically measured outcomes.帕金森病中的认知障碍:患者自我报告结果与临床测量结果之间的关联。
Parkinsonism Relat Disord. 2016 Dec;33:107-114. doi: 10.1016/j.parkreldis.2016.09.025. Epub 2016 Sep 27.
3
Use of the Montreal Cognitive Assessment and Alzheimer's Disease-8 as cognitive screening measures in Parkinson's disease.将蒙特利尔认知评估量表和阿尔茨海默病8项量表用作帕金森病的认知筛查工具。
Int J Geriatr Psychiatry. 2016 Mar;31(3):264-72. doi: 10.1002/gps.4320. Epub 2015 Jul 14.
4
Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.蒙特利尔认知评估用于早期帕金森病认知功能下降的筛查和预测。
Parkinsonism Relat Disord. 2014 Nov;20(11):1145-8. doi: 10.1016/j.parkreldis.2014.08.002. Epub 2014 Aug 14.
5
Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.临床变量和生物标志物在新诊断帕金森病患者认知障碍预测中的作用:一项队列研究
Lancet Neurol. 2017 Jan;16(1):66-75. doi: 10.1016/S1474-4422(16)30328-3. Epub 2016 Nov 18.
6
Factor structure of the Montreal Cognitive Assessment items in a sample with early Parkinson's disease.早期帕金森病样本中蒙特利尔认知评估项目的因子结构
Parkinsonism Relat Disord. 2017 Aug;41:104-108. doi: 10.1016/j.parkreldis.2017.05.023. Epub 2017 May 25.
7
Domain specific cognitive impairment in Parkinson's patients with mild cognitive impairment.帕金森病伴轻度认知障碍患者的特定领域认知障碍。
J Clin Neurosci. 2020 May;75:99-105. doi: 10.1016/j.jocn.2020.03.015. Epub 2020 Mar 16.
8
Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.帕金森病认知障碍的筛查:通过子测验加权提高蒙特利尔认知评估量表(MoCA)的诊断效用
PLoS One. 2016 Jul 20;11(7):e0159318. doi: 10.1371/journal.pone.0159318. eCollection 2016.
9
Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale-2 in Parkinson's disease.MoCA 与 Mattis 痴呆评定量表-2 在帕金森病中的比较敏感性。
Mov Disord. 2019 Feb;34(2):285-291. doi: 10.1002/mds.27575. Epub 2018 Dec 10.
10
The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease.蒙特利尔认知评估作为帕金森病认知障碍的筛查工具。
Mov Disord. 2008 May 15;23(7):1043-1046. doi: 10.1002/mds.22017.

引用本文的文献

1
A domain-based framework for cognitive profile identification in Parkinson's disease across diverse samples.一种基于领域的框架,用于跨不同样本识别帕金森病的认知概况。
Front Neuroanat. 2025 Jun 19;19:1566835. doi: 10.3389/fnana.2025.1566835. eCollection 2025.
2
Domain-specific brain regions are associated with cognitive impairment in progressive supranuclear palsy.特定领域的脑区与进行性核上性麻痹的认知障碍相关。
Neuroimage Rep. 2025 Mar 4;5(1):100247. doi: 10.1016/j.ynirp.2025.100247. eCollection 2025 Mar.
3
Cluster analysis identifies long COVID subtypes in Belgian patients.聚类分析确定了比利时患者中的长新冠亚型。
Biol Methods Protoc. 2024 Oct 9;9(1):bpae076. doi: 10.1093/biomethods/bpae076. eCollection 2024.
4
Associations between cognitive screening performance and motor symptoms in Parkinson's disease:a systematic review and meta-analysis.帕金森病认知筛查表现与运动症状之间的关联:一项系统综述和荟萃分析。
Dement Neuropsychol. 2024 Sep 2;18:e20230102. doi: 10.1590/1980-5764-DN-2023-0102. eCollection 2024.
5
The relationship between obstructive sleep apnea and visual hallucinations in PD patients: a polysomnography study.帕金森病患者阻塞性睡眠呼吸暂停与视幻觉之间的关系:一项多导睡眠图研究。
Front Neurol. 2024 Jan 11;14:1275660. doi: 10.3389/fneur.2023.1275660. eCollection 2023.
6
Early postoperative neurocognitive complications in elderly patients: comparing those with and without preexisting mild cognitive impairment- a prospective study.老年患者术后早期神经认知并发症:伴有和不伴有预先存在的轻度认知障碍的比较-一项前瞻性研究。
BMC Geriatr. 2024 Jan 22;24(1):84. doi: 10.1186/s12877-024-04663-5.
7
Cognitive Profiles Stratified by Education Using Montreal Cognitive Assessment in Parkinson's Disease Patients with Freezing of Gait.在帕金森病冻结步态患者中使用蒙特利尔认知评估按教育程度分层的认知概况
Neuropsychiatr Dis Treat. 2024 Jan 8;20:25-34. doi: 10.2147/NDT.S439131. eCollection 2024.
8
Salience network and cognitive impairment in Parkinson's disease.帕金森病中的突显网络与认知障碍
medRxiv. 2023 Oct 14:2023.10.13.23296825. doi: 10.1101/2023.10.13.23296825.
9
Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson's disease.神经丝轻链作为帕金森病中LRRK2突变与痴呆之间的介导因子。
NPJ Parkinsons Dis. 2023 Sep 12;9(1):132. doi: 10.1038/s41531-023-00572-3.
10
Using shoe-mounted inertial sensors and stepping exergames to assess the motor-cognitive status of older adults: A correlational study.使用鞋载惯性传感器和踏步健身游戏评估老年人的运动认知状态:一项相关性研究。
Digit Health. 2023 Mar 28;9:20552076231167001. doi: 10.1177/20552076231167001. eCollection 2023 Jan-Dec.

本文引用的文献

1
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.早期未经治疗的帕金森病患者的认知功能和神经精神症状
Mov Disord. 2015 Jun;30(7):919-27. doi: 10.1002/mds.26170. Epub 2015 Mar 4.
2
Evolution of mild cognitive impairment in Parkinson disease.帕金森病患者轻度认知障碍的演变。
Neurology. 2013 Jul 23;81(4):346-52. doi: 10.1212/WNL.0b013e31829c5c86. Epub 2013 Jun 21.
3
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.帕金森病轻度认知障碍的诊断标准:运动障碍学会工作组指南。
Mov Disord. 2012 Mar;27(3):349-56. doi: 10.1002/mds.24893. Epub 2012 Jan 24.
4
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.MDS 工作组关于帕金森病轻度认知障碍:对 PD-MCI 的批判性回顾。
Mov Disord. 2011 Aug 15;26(10):1814-24. doi: 10.1002/mds.23823. Epub 2011 Jun 9.
5
Systematic review of levodopa dose equivalency reporting in Parkinson's disease.帕金森病左旋多巴剂量等效报告的系统评价。
Mov Disord. 2010 Nov 15;25(15):2649-53. doi: 10.1002/mds.23429.
6
The MoCA: well-suited screen for cognitive impairment in Parkinson disease.MoCA:适合帕金森病认知障碍的筛查工具。
Neurology. 2010 Nov 9;75(19):1717-25. doi: 10.1212/WNL.0b013e3181fc29c9.
7
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.蒙特利尔认知评估量表(MoCA)和简易精神状态检查表(MMSE)在帕金森病中检测轻度认知障碍(MCI)和痴呆的效度。
Neurology. 2009 Nov 24;73(21):1738-45. doi: 10.1212/WNL.0b013e3181c34b47.
8
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.运动障碍协会赞助的统一帕金森病评定量表修订版(MDS-UPDRS):量表介绍及临床测量测试结果
Mov Disord. 2008 Nov 15;23(15):2129-70. doi: 10.1002/mds.22340.
9
A review of screening tests for cognitive impairment.认知障碍筛查测试综述。
J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):790-9. doi: 10.1136/jnnp.2006.095414. Epub 2006 Dec 18.
10
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.蒙特利尔认知评估量表(MoCA):一种用于轻度认知障碍的简易筛查工具。
J Am Geriatr Soc. 2005 Apr;53(4):695-9. doi: 10.1111/j.1532-5415.2005.53221.x.